Mhandire Kudakwashe, Pharo Gavin, Kandawasvika Gwendolene Q, Duri Kerina, Swart Marelize, Stray-Pedersen Babill, Dandara Collet
1 Pharmacogenetics Research Group, Division of Human Genetics, Department of Clinical Laboratory Sciences, Faculty of Health Sciences, University of Cape Town , South Africa .
OMICS. 2014 Jul;18(7):454-60. doi: 10.1089/omi.2013.0131. Epub 2014 Mar 6.
Mannose binding lectin (MBL) is a pathogen pattern recognition protein involved in antimicrobial activities. Variation in MBL2 gene has been extensively implicated in differential outcomes of infectious diseases in studies conducted outside Africa, but virtually very little is known on the role of this candidate gene in the African continent. We investigated human genetic variations in MBL2 in a Zimbabwean pediatric population and their putative associations with HIV infection in perinatally exposed children. One hundred and four children aged 7 to 9 years comprising 68 perinatally exposed to HIV (32 who were born infected and 36 who were uninfected) and 36 unexposed controls were recruited. DNA samples were genotyped for MBL2 polymorphisms using PCR-RFLP and sequencing. HIV infected children had markedly variable and significantly lower mean height (p=0.03) and weight (p=0.005) when compared to the uninfected children. Using all samples, frequencies for MBL2 genetic variants for the Zimbabwean population were calculated. Twelve single nucleotide polymorphisms were observed and minor alleles occurred with the following frequencies: -550C>G (G: 0.02), -435G>A (A: 0.08), -428A>C (C: 0.39), -394A>G (A: 0.39), -328AGAGAA ins/del (AGAGAA ins: 0.44), -245G>A (A: 0.05), -221C>G (C: 0.12), -111A>T (T: 0.10), -70C>T (C: 0.46), +4C>T (C: 0.45), novel -595G>A (A: 0.02), and 170G>A (0.24). We found that the MBL2 +4T variant displayed a trend for association with reduced risk of HIV transmission from mother-to-child but the remaining vast majority of the genetic markers did not show a significant association. We conclude (1) the MBL2 gene is highly polymorphic in the Zimbabwean population, and (2) MBL2 genetic variation does not appear to play a major role in influencing the risk of mother-to-child HIV transmission in our study sample. These observations contest the hitherto significant role of this candidate gene for HIV transmission from mother-to-child in non-African populations and thus, further speak to the limits of extrapolating genomic association studies directly to the African populations from studies conducted elsewhere. It is hoped that more OMICS research in a diverse set of African countries can shed further light on the putative role (or the lack thereof ) of this candidate gene in HIV transmission in the continent, a major global health burden in Africa.
甘露糖结合凝集素(MBL)是一种参与抗菌活动的病原体模式识别蛋白。在非洲以外地区进行的研究中,MBL2基因变异与传染病的不同结局广泛相关,但实际上对该候选基因在非洲大陆的作用知之甚少。我们调查了津巴布韦儿科人群中MBL2的人类基因变异及其与围产期暴露儿童HIV感染的假定关联。招募了104名7至9岁的儿童,其中包括68名围产期暴露于HIV的儿童(32名出生时感染,36名未感染)和36名未暴露的对照。使用PCR-RFLP和测序对DNA样本进行MBL2多态性基因分型。与未感染儿童相比,HIV感染儿童的平均身高(p = 0.03)和体重(p = 0.005)明显变化且显著较低。使用所有样本,计算了津巴布韦人群MBL2基因变异的频率。观察到12个单核苷酸多态性,次要等位基因出现频率如下:-550C>G(G:0.02),-435G>A(A:0.08),-428A>C(C:0.39),-394A>G(A:0.39),-328AGAGAA插入/缺失(AGAGAA插入:0.44),-245G>A(A:0.05),-221C>G(C:0.12),-111A>T(T:0.10),-70C>T(C:0.46),+4C>T(C:0.45),新的-595G>A(A:0.02)和170G>A(0.24)。我们发现MBL +4T变异体显示出与降低母婴HIV传播风险相关的趋势,但其余绝大多数遗传标记未显示出显著关联。我们得出结论:(1)MBL2基因在津巴布韦人群中高度多态,(2)在我们的研究样本中,MBL2基因变异似乎在影响母婴HIV传播风险方面不起主要作用。这些观察结果对该候选基因在非非洲人群中母婴HIV传播的迄今重要作用提出了质疑,因此,进一步说明了将基因组关联研究直接从其他地方进行的研究外推到非洲人群的局限性。希望在更多不同的非洲国家进行的更多组学研究能够进一步阐明该候选基因在非洲大陆HIV传播中的假定作用(或缺乏作用),这是非洲的一项主要全球健康负担。